/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Dr. Spartera is a consultant cardiologist at the Great Western Hospital NHS and at Oxford University Hospitals NHS. He is specialized in complex cardiac imaging (cardiovascular MRI, TOE, DSE, CT, including structural and complex imaging).
Dr Spartera obtained his MD and cardiology CCT at San Raffaele University hospital (Milan, IT) and he was subsequently awarded his PhD at the University of Oxford (UK) in 2022.
His research, funded by NIHR Oxford Biomedical Research Centre and BHF, is carried out at the Oxford Centre for Magnetic Resonance and is focused on studying mechanisms of cardioembolism and cardiovascular flow. It aims at developing novel imaging biomarkers to predict risk of ischaemic stroke.
Dr. Spartera is also an investigator of LOSE-AF trial (NCT03713775), a Randomized Controlled Trial to investigate whether in older overweight/obese patients with Atrial Fibrillation (AF) weight loss can improve AF outcomes and physical performance as compared to usual care.
